Opinion|Videos|July 25, 2025

Addressing Cardiovascular Risk and Intervening Early—Recording

In a webinar, experts discussed cardiovascular disease prevention strategies, emphasizing personalized risk assessments and emerging treatments to combat this health crisis.

Cardiovascular disease remains the leading cause of mortality in the US, and despite years of encouraging progress, there remains an urgent need for a focus on prevention.

Related to this article

Andrew D. Zelenetz, MD, PhD, is the chair of the NCCN B-cell Lymphomas panel.  | Image: LinkedIn
The National Comprehensive Cancer Network update on mantle cell lymphoma puts covalent BTK inhibitors, MRD testing, and TP53 sequencing at the center of frontline care, while adding pirtobrutinib and a pair of CAR T-cell therapies for disease that progresses on a BTK inhibitor.